Liberty Health Sciences Gains Control of Florida Medical Cannabis License

Liberty Health Sciences Inc.’s License Transfer Application Approved by the Florida Department of Health, Office of Medical Marijuana Use

TORONTO, Sept. 29, 2017 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCBB: LHSIF) (“Liberty” or the “Company”) today announced that the Florida Department of Health, Office of Medical Marijuana Use, approved the transfer of the license to cultivate, process and dispense medical marijuana in the State from Chestnut Hill Tree Farm LLC (“Chestnut”) to Liberty, effective September 28, 2017.

This approval, the first of its kind in the State of Florida, sees Liberty take over full ownership of Chestnut’s Medical Marijuana Treatment Center (“MMTC”) license, facility and operations. The change of ownership makes Liberty an officially licensed MMTC, with authorization to cultivate, process, and dispense medical marijuana in the State. Prior to obtaining the approval to transfer the license, Liberty was operating under a State-approved exclusive Management Agreement with Chestnut. With the approval, the Management Agreement dissolves.

We’re thrilled with the Florida Department of Health’s decision to approve the transfer of the license. We look forward to continuing to help patients in the State of Florida improve the quality of their lives. The agreements we’ve established with Aphria allow us to employ their industry leading and proven cultivation and processing techniques, while offering a full array of Aphria products to the citizens of Florida via home delivery and at our forthcoming Medical Cannabis Education Centers.

George Scorsis, CEO and Director of Liberty

Liberty’s previously announced Part II expansion plans for its Alachua, Florida facility remain on track. This expansion will increase Liberty’s annual medical cannabis production to 3,000 kgs by March 2018.

For more information on Aphria, please visit

For more information on Liberty, please visit

About Liberty Health Sciences Inc.

Liberty Health Sciences Inc. (“Liberty”) is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal. Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near and mid-term opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.

Original press release:

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter